ENPH analyst scorecard
71 rating actions on ENPH in the last 12 months. Of 106 price targets that resolved, 50 were reached while they stood, 52 were replaced by the same firm first, and 4 fell short at their deadline. Ratings: 30% Buy-type, 54% Hold-type, 17% Sell-type. Consensus target $42, 65% above the last close.
Checked through 2026-10-29 · last close $25.58 (2026-10-29). Rebuilt every morning.
Targets reached while they stood
47.2% 50 of 106
Replaced before the deadline
49.1%
Short at the deadline
3.8%
Ratings vs XLK
5 of 11
Buy / Hold / Sell, 12 mo
30 / 54 / 17%
Consensus target
$42 +65.3%
What the Holds say: 36 Hold-type ratings on ENPH in the last 12 months carried a median target +6% from the price on the day; 31% sat below it.
The 7 upgrades on ENPH came after an average +20.6% move in the 30 days before them.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Citigroup | Neutral | 2026-09-29 | $37 | 5 | 2 | 7 | — |
| Goldman Sachs | Buy | 2026-10-28 | $40 | 3 | 5 | 8 | — |
| Jefferies | Buy | 2026-09-21 | $42 | 3 | 5 | 8 | — |
| Barclays | Equal-Weight | 2026-10-29 | $26 | 2 | 8 | 10 | 1 of 1 |
| Susquehanna | Neutral | 2026-10-28 | $26 | 2 | 4 | 6 | — |
| RBC Capital | Outperform | 2026-10-28 | $30 | 1 | 2 | 3 | — |
| Morgan Stanley | Underweight | 2026-10-28 | $16 | 2 | 2 | 4 | 1 of 1 |
| Evercore ISI Group | In-Line | 2026-08-17 | $41 | 2 | 0 | 2 | — |
| Mizuho | Neutral | 2026-07-29 | $45 | 0 | 4 | 4 | — |
| KeyBanc | Sector Weight | 2026-01-05 | — | 1 | 0 | 1 | — |
| Northland Capital Markets | Outperform | 2025-12-29 | $62 | 1 | 0 | 2 | 0 of 1 |
| JPMorgan | Neutral | 2026-10-28 | $29 | 4 | 4 | 8 | — |
| Wells Fargo | Overweight | 2026-10-28 | $34 | 3 | 5 | 8 | 0 of 1 |
| Oppenheimer | Perform | 2026-10-28 | $56 | 1 | 3 | 4 | 0 of 1 |
| TD Cowen | Hold | 2026-07-20 | $48 | 2 | 1 | 3 | — |
| GLJ Research | Sell | 2026-10-28 | $21 | 1 | 6 | 7 | 1 of 1 |
| BMO Capital | Market Perform | 2026-10-28 | $25 | 4 | 0 | 4 | — |
| Bernstein | Market Perform | 2026-10-28 | $40 | 0 | 1 | 1 | — |
| Freedom Broker | Hold | 2026-02-05 | $44 | 1 | 0 | 1 | — |
| Roth Capital | Buy | 2026-02-04 | $55 | 1 | 0 | 1 | — |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor ENPH carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-29 | Barclays | Equal-Weight | maintained | $25.58 | $26 | within 5% of price when set | -19.6% |
| 2026-10-28 | JPMorgan | Neutral | maintained | $24.99 | $29 | running to 2027-10-28 | -19.1% |
| 2026-10-28 | BMO Capital | Market Perform | maintained | $24.99 | $25 | within 5% of price when set | -19.1% |
| 2026-10-28 | Goldman Sachs | Buy | maintained | $24.99 | $40 | running to 2027-10-28 | -19.1% |
| 2026-10-28 | RBC Capital | Outperform | maintained | $24.99 | $30 | running to 2027-10-28 | -19.1% |
| 2026-10-28 | Wells Fargo | Overweight | maintained | $24.99 | $34 | running to 2027-10-28 | -19.1% |
| 2026-10-28 | Susquehanna | Neutral | maintained | $24.99 | $26 | within 5% of price when set | -19.1% |
| 2026-10-28 | GLJ Research | Sell | reiterated | $24.99 | $21 | running to 2027-10-28 | -19.1% |
| 2026-10-28 | Oppenheimer | Outperform → Perform | downgrade | $24.99 | — | no target | -19.1% |
| 2026-10-28 | Morgan Stanley | Underweight | maintained | $24.99 | $16 | running to 2028-04-28 | -19.1% |
| 2026-10-28 | Bernstein | Market Perform | maintained | $24.99 | $40 | running to 2027-10-28 | -19.1% |
| 2026-10-26 | GLJ Research | Sell | maintained | $30.36 | $21 | running to 2027-10-26 | -6.3% |
| 2026-10-21 | BMO Capital | Market Perform | maintained | $31.99 | $28 | reached 2026-10-28 | -8.0% |
| 2026-10-19 | JPMorgan | Neutral | maintained | $30.63 | $35 | replaced 2026-10-28, new $29 | -11.6% |
| 2026-10-14 | Morgan Stanley | Underweight | maintained | $29.35 | $24 | replaced 2026-10-28, new $16 | -19.9% |
| 2026-10-14 | Susquehanna | Neutral | maintained | $29.35 | $35 | replaced 2026-10-28, new $26 | -19.9% |
| 2026-10-06 | Barclays | Equal-Weight | maintained | $33.91 | $44 | replaced 2026-10-29, new $26 | -6.8% |
| 2026-09-29 | Citigroup | Neutral | maintained | $31.83 | $37 | running to 2027-09-29 | -14.6% |
| 2026-09-21 | Jefferies | Buy | maintained | $34.76 | $42 | running to 2027-09-21 | -10.0% |
| 2026-09-21 | Goldman Sachs | Buy | maintained | $34.76 | $47 | replaced 2026-10-28, new $40 | -10.0% |
| 2026-08-17 | Evercore ISI Group | In-Line | maintained | $38.65 | $41 | running to 2027-08-17 | -7.0% |
| 2026-07-30 | Citigroup | Neutral | maintained | $37.38 | $40 | reached 2026-08-04 | -24.1% |
| 2026-07-30 | Susquehanna | Neutral | maintained | $37.38 | $39 | within 5% of price when set | -24.1% |
| 2026-07-29 | RBC Capital | Outperform | maintained | $35.07 | $47 | replaced 2026-10-28, new $30 | -27.4% |
| 2026-07-29 | Oppenheimer | Outperform | maintained | $35.07 | $56 | running to 2027-07-29 | -27.4% |
| 2026-07-29 | Wells Fargo | Overweight | maintained | $35.07 | $44 | replaced 2026-10-28, new $34 | -27.4% |
| 2026-07-29 | GLJ Research | Sell | reiterated | $35.07 | $24 | replaced 2026-10-26, new $21 | -27.4% |
| 2026-07-29 | BMO Capital | Market Perform | maintained | $35.07 | $37 | reached 2026-07-30 | -27.4% |
| 2026-07-29 | Mizuho | Neutral | maintained | $35.07 | $45 | running to 2027-07-29 | -27.4% |
| 2026-07-28 | GLJ Research | Sell | maintained | $36.32 | $24 | replaced 2026-10-26, new $21 | -23.7% |
| 2026-07-20 | TD Cowen | Hold | maintained | $39.46 | $48 | running to 2027-07-20 | -24.5% |
| 2026-07-10 | Susquehanna | Neutral | maintained | $44.83 | $45 | within 5% of price when set | -11.3% |
| 2026-06-18 | Barclays | Underweight → Equal-Weight | upgrade | $52.28 | $51 | within 5% of price when set | +11.8% |
| 2026-06-17 | Bernstein | Market Perform | initiated | $47.78 | $56 | replaced 2026-10-28, new $40 | -3.8% |
| 2026-06-12 | Jefferies | Buy | maintained | $54.59 | $64 | replaced 2026-09-21, new $42 | +30.0% |
| 2026-06-11 | GLJ Research | Sell | reiterated | $54.93 | $22 | replaced 2026-07-28, new $24 | +46.6% |
| 2026-05-20 | Goldman Sachs | Buy | maintained | $53.15 | $57 | reached 2026-05-21 | +56.9% |
| 2026-05-05 | Barclays | Underweight | maintained | $36.02 | $30 | replaced 2026-06-18, new $51 | +3.1% |
| 2026-05-04 | Evercore ISI Group | In-Line | maintained | $32.54 | $37 | reached 2026-05-11 | -6.8% |
| 2026-04-30 | Citigroup | Neutral | maintained | $32.96 | $31 | replaced 2026-07-30, new $40 | -12.8% |
| 2026-04-30 | Susquehanna | Neutral | maintained | $32.96 | $32 | within 5% of price when set | -12.8% |
| 2026-04-29 | JPMorgan | Neutral | maintained | $31.19 | $35 | reached 2026-05-05 | -12.5% |
| 2026-04-29 | Jefferies | Buy | maintained | $31.19 | $41 | reached 2026-05-13 | -12.5% |
| 2026-04-29 | TD Cowen | Hold | maintained | $31.19 | $35 | reached 2026-05-05 | -12.5% |
| 2026-04-29 | Oppenheimer | Outperform | maintained | $31.19 | $57 | reached 2026-05-21 | -12.5% |
| 2026-04-29 | Wells Fargo | Overweight | maintained | $31.19 | $45 | reached 2026-05-14 | -12.5% |
| 2026-04-21 | Citigroup | Neutral | maintained | $33.62 | $37 | replaced 2026-04-30, new $31 | -23.8% |
| 2026-04-09 | Susquehanna | Neutral | maintained | $31.26 | $36 | reached 2026-04-23 | -28.3% |
| 2026-04-08 | Barclays | Underweight | maintained | $32.56 | $31 | within 5% of price when set | -20.3% |
| 2026-03-26 | Jefferies | Buy | maintained | $40.18 | $54 | replaced 2026-04-29, new $41 | -19.2% |
| 2026-02-25 | Jefferies | Hold → Buy | upgrade | $48.49 | $57 | replaced 2026-03-26, new $54 | +23.0% |
| 2026-02-05 | Freedom Broker | Hold | maintained | $47.27 | $44 | reached 2026-02-13 | +36.0% |
| 2026-02-04 | Citigroup | Neutral | maintained | $51.67 | $41 | reached 2026-03-06 | +52.0% |
| 2026-02-04 | Goldman Sachs | Buy | maintained | $51.67 | $51 | within 5% of price when set | +52.0% |
| 2026-02-04 | Roth Capital | Buy | reiterated | $51.67 | $55 | reached 2026-05-21 | +52.0% |
| 2026-02-04 | JPMorgan | Neutral | maintained | $51.67 | $39 | reached 2026-03-27 | +52.0% |
| 2026-02-04 | Oppenheimer | Outperform | maintained | $51.67 | $68 | replaced 2026-04-29, new $57 | +52.0% |
| 2026-02-04 | Wells Fargo | Overweight | maintained | $51.67 | $50 | within 5% of price when set | +52.0% |
| 2026-02-04 | BMO Capital | Underperform → Market Perform | upgrade | $51.67 | $41 | reached 2026-03-06 | +52.0% |
| 2026-01-22 | Citigroup | Sell → Neutral | upgrade | $40.48 | $37 | reached 2026-01-30 | +25.6% |
| 2026-01-20 | Goldman Sachs | Neutral → Buy | upgrade | $34.52 | $45 | reached 2026-02-04 | +3.8% |
| 2026-01-15 | Barclays | Underweight | maintained | $35.36 | $35 | within 5% of price when set | +11.0% |
| 2026-01-05 | KeyBanc | Underweight → Sector Weight | upgrade | $34.00 | — | no target | +8.8% |
| 2025-12-29 | Northland Capital Markets | Outperform | maintained | $33.13 | $62 | reached 2026-05-21 | +14.8% |
| 2025-12-18 | Goldman Sachs | Sell → Neutral | upgrade | $32.96 | $29 | replaced 2026-01-20, new $45 | +19.4% |
| 2025-12-08 | JPMorgan | Neutral | maintained | $31.24 | $33 | reached 2025-12-11 | +3.4% |
| 2025-10-30 | Freedom Broker | Hold | maintained | $30.13 | $31 | within 5% of price when set | — |
| 2025-10-30 | Morgan Stanley | Underweight | maintained | $30.13 | $26 | replaced 2026-10-14, new $24 | — |
| 2025-10-29 | Citigroup | Sell | maintained | $31.14 | $31 | within 5% of price when set | — |
| 2025-10-29 | RBC Capital | Sector Perform | maintained | $31.14 | $31 | within 5% of price when set | — |
| 2025-10-29 | JPMorgan | Neutral | maintained | $31.14 | $37 | replaced 2025-12-08, new $33 | — |
Also in Solar & Clean
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.